- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lower serum Uromodulin levels tied to high risk of kidney failure and related mortality
![Lower serum Uromodulin levels tied to high risk of kidney failure and related mortality Lower serum Uromodulin levels tied to high risk of kidney failure and related mortality](https://medicaldialogues.in/h-upload/2022/11/05/750x450_190033-chronic-kidney-disease.webp)
Prior studies of uromodulin, the most abundant protein in urine, and kidney disease have focused primarily on urinary uromodulin levels. The current study evaluated associations of serum uromodulin levels with risk of end-stage kidney disease and mortality in a cohort of African American adults with hypertension and chronic kidney disease. The research, recently published in the American Journal of Kidney Diseases (AJKD), found that participants with lower levels of uromodulin at baseline were more likely to develop end-stage kidney disease, even after accounting for baseline kidney measures.
Similarly, participants who experienced steeper annual declines in uromodulin also had a heightened risk kidney failure. Neither baseline nor annual change in uromodulin was associated with mortality. Levels of uromodulin can be impacted by conventional treatments, such as intensive blood pressure control and ramipril therapy. Serum uromodulin is a promising biomarker of kidney health.
Reference:
Teresa K. Chen, Michelle M. Estrella, Lawrence J. Appel, Wassim Obeid, Chirag R. Parikh, Morgan E. Grams, Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial, https://doi.org/10.1053/j.ajkd.2023.05.017
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751